Additionally, ZKSCAN3-shRNA expression profoundly inhibits the initiation and progression of tumors in mice bearing xenografts, highlighting the significant impact of ZKSCAN3 on bladder cancer growth and indicating that inhibiting ZKSCAN3 could serve as a viable therapeutic approach for treating bladder cancer [41,49]. This evidence concerns the gene ZKSCAN3 and urinary bladder carcinoma.